Cargando…

Reply to Jakovac: COVID-19, vitamin D, and type I interferon

Detalles Bibliográficos
Autores principales:	Gauzzi, Maria Cristina, Fantuzzi, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Physiological Society 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365833/ https://www.ncbi.nlm.nih.gov/pubmed/32672049 http://dx.doi.org/10.1152/ajpendo.00315.2020

Ejemplares similares

Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?
por: Slominski, Andrzej T., et al.
Publicado: (2020)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

Reply to: A key role for vitamin D binding protein in COVID-19?
por: Arab-Ahmadi, Mehran, et al.
Publicado: (2021)

Authors’ Reply: Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Charoenngam, Nipith, et al.
Publicado: (2021)

Reply on “Vitamin D and coronary atherosclerosis”
por: Lee, Ah-Young, et al.
Publicado: (2017)

Redefining vitamin D deficiency: Reply to comments
por: Garg, MK, et al.
Publicado: (2014)

Reply - Letter to the Editor: Vitamin D deficiency in critically ill COVID-19 ARDS patients
por: Notz, Quirin, et al.
Publicado: (2022)

Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy—reply to Dr Helga Rhein
por: Harvey, Nicholas C., et al.
Publicado: (2021)

Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”
por: Davoudi-Monfared, Effat, et al.
Publicado: (2021)

Adjuvant interferon in the treatment of melanoma – reply
por: Middleton, M R
Publicado: (2000)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Vitamin D and COVID-19 disease: don’t believe everything you read in the papers! Reply to Dr William B. Grant
por: Harvey, Nicholas C., et al.
Publicado: (2021)

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
por: Soeiro, Thomas, et al.
Publicado: (2021)

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
por: Scordio, Mirko, et al.
Publicado: (2022)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Role of Vitamin D in COVID-19: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Reply to W.B. Grant ‘Re: Vitamin D deficiency among northern Native Peoples’
por: Frost, Peter
Publicado: (2012)

Vitamin D receptor gene BsmI polymorphism with type 2 diabetes mellitus
por: Joob, Beuy, et al.
Publicado: (2020)

Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Association between low vitamin D and COVID-19: don’t forget the vitamin D binding protein
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Vitamin D status and COVID-19 in older adults
por: Mandal, Amit K. J., et al.
Publicado: (2020)

Prognostic implications of vitamin D in patients with COVID-19
por: Hosack, Tom, et al.
Publicado: (2020)

Role of vitamin D deficiency and comorbidities in COVID-19
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2022)

ATG13 restricts viral replication by induction of type I interferon
por: Du, Jiang‐long, et al.
Publicado: (2019)

Vitamin D binding protein and its polymorphisms may explain the link between vitamin D deficiency and COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Vitamin D supplementation in COVID-19: A friend or foe?
por: Mansour, Asieh, et al.
Publicado: (2020)

Is Vitamin D One of the Key Elements in COVID-19 Days?
por: Aslan, M. T., et al.
Publicado: (2020)

Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19
por: Khemka, Aakriti, et al.
Publicado: (2020)

Spurious undermining of the adjuvant role of vitamin D in COVID-19
por: Pal, Rimesh, et al.
Publicado: (2021)

Vitamin D(3) Administration to Patients with Confirmed COVID-19
por: RASHEDI, Jalil, et al.
Publicado: (2020)

Increased risk for Covid-19 in patients with Vitamin D deficiency
por: Katz, Joseph
Publicado: (2021)

Vitamin D levels and COVID 19 risk and death; is there an association?
por: Al Kiyumi, Maisa Hamed
Publicado: (2022)

Reply to: Singularities of AED implementation in occupational setting and COVID-19 pandemic
por: Sarkisian, Laura, et al.
Publicado: (2021)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3cr3e2t20d0itfmb39g195bspc